News

AddToAny

Google+ Facebook Twitter Twitter

Non-COVID-19 respiratory infections statistics

An increase in the number of non-COVID-19 respiratory infections should be expected this winter, say scientists.

The warning comes following the results of a new study that found that over 55% of respiratory disease hospitalisations during the pandemic’s peak in 2021–2022 were caused by non-SARS-CoV-2 infections.

The University of Bristol-led study is the first to compare the number of hospitalisations from respiratory disease infections caused by COVID-19 and non-SARS-CoV-2 infections. 

Using data from 135,014 hospitalisations from two large hospitals in Bristol between August 2020 and November 2021, researchers identified 12,557 admissions attributable to acute lower respiratory tract disease (aLRTD) with patients admitted with signs or symptoms of respiratory infections including cough, fever, pleurisy, or a clinical or radiological aLRTD diagnosis.

Of these, 12,248 (98%) patients, comprising mainly older adults, consented to participate in the study.

The team show that of the 12,248 aLRTD hospitalisations, 55% (6,909) were due to infection with no evidence of SARS-CoV-2, while confirmed SARS-CoV-2 infection only accounted for 26% (3,178) of respiratory infections. The remaining 17% (2,161) were due to infection with no infective cause.

bit.ly/3dq6PdO

Image credit | Getty

Related Articles

neutrophil cell trapping bacteria Image Credit | Science Photo Library-p2760184

Cancer and stress breakthrough

Stress hormones can trigger the formation of structures that make body tissues more susceptible to metastasis, research has found.

Tuberculosis vaccine bacteria-Image Credit | Science Photo Library - b2201433

“TB vaccine shrinks mice cancer tumours”

A new study found that a single dose of Bacillus Calmette-Guérin (BCG), the vaccine for tuberculosis (TB), reduced liver tumour burden and extended the survival of mice with liver cancer.

genetics mutations cancer - CREDIT - alamy-2jkftm9

The evolution of cancer

Charlie Swanton outlines the work in cancer research that led to him being awarded a 2024 Louis-Jeantet Prize for translational medicine.

A nurse takes the blood pressures of a woman as she waits with an infant at Ndirande Health Centre in Blantyre on February 21, 2018 - Image credit - Getty-922184246

Vaccine effective in preventing typhoid fever

A single dose of the typhoid conjugate vaccine Typbar TCV provides lasting efficacy in preventing typhoid fever in children aged nine months to 12 years old, according to a new study.

Top